Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Corvus Pharmaceuticals Inc. logo

Corvus Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

2.35
 
USD
  
0.04
  
(1.73%)
Optionable: Yes  Market Cap: 114 M  90-day average vol: 204,698

Previous close: 2.31  Open: 2.32  Bid: 2.14  Ask: 2.41
52 week range    
0.61   
   4.19
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Monday 26th February 2024
50
MarketXLS Rank
60
Value
61
Technical
31
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0 B-2.52.03

OTLC

0 B-1.90.17

OVAT-CA

Financials

CRVS Income Statement

Annual
Invalid dateDec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Basic EPS from continuing operations-1.59-0.2-1.03-0.89
Basic EPS total-1.59-0.2-1.03-0.89
Basic weighted shares outstanding15 M20 M28 M29 M29 M42 M47 M
Depreciation500000.0400000.0
DepreciationAndAmortization500000.0400000.0
Diluted EPS total-2.36-2.72-1.71-1.59-0.2-1.03-0.89
Diluted normalized net income/share-1.71-1.03-0.89
Diluted weighted shares outstanding15 M20 M28 M29 M42 M47 M
GainOnSaleOfBusiness37 M
GainOnSaleOfPPE22000.0
GainOnSaleOfSecurity-234000.0-5 M-10 M
GeneralAndAdministrativeExpense8 M10 M11 M11 M12 M10 M8 M
Income before tax-37 M-57 M-49 M-49 M-7 M-43 M-43 M
Net income from total operations-36 M-56 M-47 M-47 M-6 M-43 M-41 M
NetIncomeCommonStockholders-36 M-56 M-47 M-47 M-6 M-43 M-41 M
NetIncomeContinuousOperations-36 M-56 M-47 M-47 M-6 M-43 M-41 M
NetIncomeFromOtherGainsLosses601000.0861000.02 M2 M540000.0185000.01 M
Normalized income-34 M-34 M
Operating income-37 M-57 M-49 M-49 M-44 M-39 M-33 M
Operating income before depreciation (EBITDA)-36 M-56 M-48 M-48 M-6 M-43 M-42 M
OperatingExpense-37 M-57 M49 M49 M44 M39 M33 M
Other income net-37 M5 M10 M
OtherGandA8 M10 M11 M11 M12 M10 M8 M
OtherOperatingExpenses-49 M-446000.0-10 M-347000.0-216000.0
RentAndLandingFees8 M10 M-748000.0
Research & development expense29 M46 M39 M38 M32 M29 M24 M
ResearchExpense29 M46 M39 M38 M32 M29 M24 M
SalariesAndWages-6 M-7 M
Selling Gen & administrative expense8 M10 M11 M11 M12 M10 M8 M
Total Income available for interest expense (EBIT)-37 M-57 M-49 M-49 M-7 M-43 M-43 M
Total common shares outstanding21 M21 M29 M29 M38 M47 M47 M
Total net income-36 M-56 M-47 M-47 M-6 M-43 M-41 M
Total ordinary shares49 M49 M49 M49 M49 M49 M49 M
TotalExpenses-37 M-57 M49 M49 M44 M39 M33 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University